US Stock MarketDetailed Quotes

Fulcrum Therapeutics (FULC)

Watchlist
  • 7.250
  • +0.290+4.17%
Close May 13 16:00 ET
  • 7.230
  • -0.020-0.28%
Post 18:28 ET
483.09MMarket Cap-6.30P/E (TTM)

Fulcrum Therapeutics (FULC) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-22.89%-18.75M
-2,608.07%-60.07M
-0.22%-16.8M
25.60%-14.19M
-123.46%-13.82M
39.66%-15.26M
97.56%-2.22M
27.62%-16.76M
16.74%-19.07M
383.37%58.9M
Net income from continuing operations
-7.00%-18.89M
-669.97%-74.88M
-22.73%-20.33M
9.68%-19.6M
-131.22%-17.3M
34.29%-17.66M
90.01%-9.73M
33.07%-16.57M
9.66%-21.7M
332.98%55.41M
Depreciation and amortization
-4.25%338K
-12.74%1.39M
-5.96%347K
-6.23%346K
-8.51%344K
-26.30%353K
-26.66%1.59M
-27.36%369K
-30.51%369K
-33.69%376K
Change In working capital
-1,375.34%-3.29M
192.04%3.91M
124.16%506K
657.32%2.29M
1,497.92%1.34M
86.47%-223K
7.91%-4.25M
-103.10%-2.09M
73.92%-410K
-112.31%-96K
-Change in receivables
--0
234.45%2.1M
--0
--0
141.96%979K
108.01%1.12M
-406.17%-1.56M
3,527.91%1.56M
-1,840.79%-1.32M
-318.85%-2.33M
-Change in prepaid assets
-109.77%-179K
219.56%1.63M
121.26%44K
101.82%44K
-162.20%-288K
128.14%1.83M
-27.33%-1.37M
66.72%-207K
-250.29%-2.42M
-39.40%463K
-Change in payables and accrued expense
2.97%-2.91M
155.35%1.45M
135.54%1.19M
52.25%2.43M
-57.05%831K
-6.24%-3M
-56.44%-2.63M
-3,727.17%-3.34M
369.48%1.6M
107.17%1.94M
-Change in other current assets
---8K
-126.39%-528K
-901.52%-529K
-99.84%3K
-100.00%-2K
--0
2,028.72%2M
414.29%66K
38,160.00%1.91M
-102.78%-1K
-Change in other working capital
-11.43%-195K
-6.14%-743K
-10.80%-195K
-12.07%-195K
-11.25%-178K
7.89%-175K
57.55%-700K
66.35%-176K
52.72%-174K
59.70%-160K
Cash from discontinued investing activities
Operating cash flow
-22.89%-18.75M
-2,608.07%-60.07M
-0.22%-16.8M
25.60%-14.19M
-123.46%-13.82M
39.66%-15.26M
97.56%-2.22M
27.62%-16.76M
16.74%-19.07M
383.37%58.9M
Investing cash flow
Cash flow from continuing investing activities
-16,400.64%-128.21M
-4.69%30.72M
-146.42%-1.05M
327.86%18.61M
211.39%13.93M
-102.04%-777K
187.84%32.23M
-87.69%2.26M
-77.13%4.35M
-162.93%-12.51M
Net PPE purchase and sale
---8K
-12.95%-314K
31.17%-159K
-373.68%-90K
---65K
--0
45.28%-278K
-200.00%-231K
70.77%-19K
--0
Net investment purchase and sale
-16,399.61%-128.2M
-4.54%31.03M
-135.73%-890K
328.06%18.7M
211.91%14M
-102.04%-777K
189.84%32.51M
-86.48%2.49M
-77.11%4.37M
-162.32%-12.51M
Cash from discontinued investing activities
Investing cash flow
-16,400.64%-128.21M
-4.69%30.72M
-146.42%-1.05M
327.86%18.61M
211.39%13.93M
-102.04%-777K
187.84%32.23M
-87.69%2.26M
-77.13%4.35M
-162.93%-12.51M
Financing cash flow
Cash flow from continuing financing activities
-312K
6,042.28%168.67M
202,673.49%168.3M
-89.92%64K
-20.16%301K
0
-97.68%2.75M
-71.08%83K
635K
165.49%377K
Net common stock issuance
----
--164.5M
----
----
----
----
--0
--0
--0
--0
Proceeds from stock option exercised by employees
--21K
51.75%4.17M
4,480.72%3.8M
-89.92%64K
-20.16%301K
--0
253.41%2.75M
-71.08%83K
--635K
165.49%377K
Net other financing activities
---333K
----
----
----
----
----
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
---312K
6,042.28%168.67M
202,673.49%168.3M
-89.92%64K
-20.16%301K
--0
-97.68%2.75M
-71.08%83K
--635K
165.49%377K
Net cash flow
Beginning cash position
234.50%198.73M
122.90%59.41M
-34.61%48.28M
-50.19%43.79M
5.42%43.38M
122.90%59.41M
-26.35%26.66M
136.85%73.83M
150.78%87.92M
14.86%41.15M
Current changes in cash
-818.50%-147.27M
325.30%139.32M
1,143.52%150.46M
131.84%4.49M
-99.11%414K
-210.62%-16.03M
443.56%32.76M
-219.19%-14.42M
-262.51%-14.09M
6,189.58%46.77M
End cash Position
18.63%51.46M
234.50%198.73M
234.50%198.73M
-34.61%48.28M
-50.19%43.79M
5.42%43.38M
122.90%59.41M
122.90%59.41M
136.85%73.83M
150.78%87.92M
Free cash flow
-22.95%-18.76M
-2,319.03%-60.38M
0.21%-16.96M
25.20%-14.28M
-123.57%-13.89M
39.72%-15.26M
97.27%-2.5M
26.87%-16.99M
16.89%-19.09M
380.74%58.9M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -22.89%-18.75M-2,608.07%-60.07M-0.22%-16.8M25.60%-14.19M-123.46%-13.82M39.66%-15.26M97.56%-2.22M27.62%-16.76M16.74%-19.07M383.37%58.9M
Net income from continuing operations -7.00%-18.89M-669.97%-74.88M-22.73%-20.33M9.68%-19.6M-131.22%-17.3M34.29%-17.66M90.01%-9.73M33.07%-16.57M9.66%-21.7M332.98%55.41M
Depreciation and amortization -4.25%338K-12.74%1.39M-5.96%347K-6.23%346K-8.51%344K-26.30%353K-26.66%1.59M-27.36%369K-30.51%369K-33.69%376K
Change In working capital -1,375.34%-3.29M192.04%3.91M124.16%506K657.32%2.29M1,497.92%1.34M86.47%-223K7.91%-4.25M-103.10%-2.09M73.92%-410K-112.31%-96K
-Change in receivables --0234.45%2.1M--0--0141.96%979K108.01%1.12M-406.17%-1.56M3,527.91%1.56M-1,840.79%-1.32M-318.85%-2.33M
-Change in prepaid assets -109.77%-179K219.56%1.63M121.26%44K101.82%44K-162.20%-288K128.14%1.83M-27.33%-1.37M66.72%-207K-250.29%-2.42M-39.40%463K
-Change in payables and accrued expense 2.97%-2.91M155.35%1.45M135.54%1.19M52.25%2.43M-57.05%831K-6.24%-3M-56.44%-2.63M-3,727.17%-3.34M369.48%1.6M107.17%1.94M
-Change in other current assets ---8K-126.39%-528K-901.52%-529K-99.84%3K-100.00%-2K--02,028.72%2M414.29%66K38,160.00%1.91M-102.78%-1K
-Change in other working capital -11.43%-195K-6.14%-743K-10.80%-195K-12.07%-195K-11.25%-178K7.89%-175K57.55%-700K66.35%-176K52.72%-174K59.70%-160K
Cash from discontinued investing activities
Operating cash flow -22.89%-18.75M-2,608.07%-60.07M-0.22%-16.8M25.60%-14.19M-123.46%-13.82M39.66%-15.26M97.56%-2.22M27.62%-16.76M16.74%-19.07M383.37%58.9M
Investing cash flow
Cash flow from continuing investing activities -16,400.64%-128.21M-4.69%30.72M-146.42%-1.05M327.86%18.61M211.39%13.93M-102.04%-777K187.84%32.23M-87.69%2.26M-77.13%4.35M-162.93%-12.51M
Net PPE purchase and sale ---8K-12.95%-314K31.17%-159K-373.68%-90K---65K--045.28%-278K-200.00%-231K70.77%-19K--0
Net investment purchase and sale -16,399.61%-128.2M-4.54%31.03M-135.73%-890K328.06%18.7M211.91%14M-102.04%-777K189.84%32.51M-86.48%2.49M-77.11%4.37M-162.32%-12.51M
Cash from discontinued investing activities
Investing cash flow -16,400.64%-128.21M-4.69%30.72M-146.42%-1.05M327.86%18.61M211.39%13.93M-102.04%-777K187.84%32.23M-87.69%2.26M-77.13%4.35M-162.93%-12.51M
Financing cash flow
Cash flow from continuing financing activities -312K6,042.28%168.67M202,673.49%168.3M-89.92%64K-20.16%301K0-97.68%2.75M-71.08%83K635K165.49%377K
Net common stock issuance ------164.5M------------------0--0--0--0
Proceeds from stock option exercised by employees --21K51.75%4.17M4,480.72%3.8M-89.92%64K-20.16%301K--0253.41%2.75M-71.08%83K--635K165.49%377K
Net other financing activities ---333K------------------------------------
Cash from discontinued financing activities
Financing cash flow ---312K6,042.28%168.67M202,673.49%168.3M-89.92%64K-20.16%301K--0-97.68%2.75M-71.08%83K--635K165.49%377K
Net cash flow
Beginning cash position 234.50%198.73M122.90%59.41M-34.61%48.28M-50.19%43.79M5.42%43.38M122.90%59.41M-26.35%26.66M136.85%73.83M150.78%87.92M14.86%41.15M
Current changes in cash -818.50%-147.27M325.30%139.32M1,143.52%150.46M131.84%4.49M-99.11%414K-210.62%-16.03M443.56%32.76M-219.19%-14.42M-262.51%-14.09M6,189.58%46.77M
End cash Position 18.63%51.46M234.50%198.73M234.50%198.73M-34.61%48.28M-50.19%43.79M5.42%43.38M122.90%59.41M122.90%59.41M136.85%73.83M150.78%87.92M
Free cash flow -22.95%-18.76M-2,319.03%-60.38M0.21%-16.96M25.20%-14.28M-123.57%-13.89M39.72%-15.26M97.27%-2.5M26.87%-16.99M16.89%-19.09M380.74%58.9M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More